+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mundipharma International Ltd. - logo

MundiPharma is an Irish owned company established in 1973. There break through drug was sustained release morphine (MST® Continus® tablets). This product was seen as a major advantage in handling cancer treatment pain. MundiPharma focus on three main areas: analgesic, oncology and respiratory therapy areas. They are constantly innovating new products to help people with debilitating diseases. Mundi Pharma is part of a worldwide network of independent associated pharmaceutical companies.

Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 120 Pages
  • Australia, New Zealand Australia, New Zealand
From
Cutaneous T-Cell Lymphoma (CTCL) - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma (CTCL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 280 Pages
  • Global
From
From
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 162 Pages
  • Global
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
  • Global
From
From
DNA topoisomerase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

DNA topoisomerase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Restless Legs Syndrome Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Restless Legs Syndrome Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 199 Pages
  • Global
From
Loading Indicator